168 related articles for article (PubMed ID: 9712068)
1. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation.
Peng HB; Spiecker M; Liao JK
J Immunol; 1998 Aug; 161(4):1970-6. PubMed ID: 9712068
[TBL] [Abstract][Full Text] [Related]
2. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription.
Grumbach IM; Chen W; Mertens SA; Harrison DG
J Mol Cell Cardiol; 2005 Oct; 39(4):595-603. PubMed ID: 16099468
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of inducible nitric oxide synthase by Acanthopanax senticosus extract in RAW264.7 macrophages.
Lin QY; Jin LJ; Cao ZH; Xu YP
J Ethnopharmacol; 2008 Jul; 118(2):231-6. PubMed ID: 18486372
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of Buthus martensi Karsch extracts on interleukin-1beta-induced expression of nitric oxide (NO) synthase and production of NO in human chondrocytes and LPS-induced NO and prostaglandin E2 production in mouse peritoneal macrophages.
Kim KS; Cho HS; Lee SD; Kim KH; Cho JY; Chung KH; Lee YC; Moon SK; Kim CH
Toxicol In Vitro; 2005 Sep; 19(6):757-69. PubMed ID: 15963682
[TBL] [Abstract][Full Text] [Related]
6. Methylxanthines and calcium-mobilizing agents inhibit the expression of cytokine-inducible nitric oxide synthase and vascular cell adhesion molecule-1 in murine microvascular endothelial cells.
Bereta M; Bereta J; Georgoff I; Coffman FD; Cohen S; Cohen MC
Exp Cell Res; 1994 Jun; 212(2):230-42. PubMed ID: 7514535
[TBL] [Abstract][Full Text] [Related]
7. Roles of tyrosine kinases in the regulation of nitric oxide synthesis in murine liver cells: modulation of NF-kappa B activity by tyrosine kinases.
Lee BS; Kang HS; Pyun KH; Choi I
Hepatology; 1997 Apr; 25(4):913-9. PubMed ID: 9096597
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells.
Walker DH; Popov VL; Crocquet-Valdes PA; Welsh CJ; Feng HM
Lab Invest; 1997 Jan; 76(1):129-38. PubMed ID: 9010456
[TBL] [Abstract][Full Text] [Related]
9. Withaferin A inhibits iNOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-kappaB in RAW 264.7 cells.
Oh JH; Lee TJ; Park JW; Kwon TK
Eur J Pharmacol; 2008 Dec; 599(1-3):11-7. PubMed ID: 18838070
[TBL] [Abstract][Full Text] [Related]
10. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-alpha.
Furuke K; Burd PR; Horvath-Arcidiacono JA; Hori K; Mostowski H; Bloom ET
J Immunol; 1999 Aug; 163(3):1473-80. PubMed ID: 10415049
[TBL] [Abstract][Full Text] [Related]
11. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB.
Pingle SC; Sanchez JF; Hallam DM; Williamson AL; Maggirwar SB; Ramkumar V
Mol Pharmacol; 2003 Jun; 63(6):1238-47. PubMed ID: 12761333
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors block VCAM-1 and ICAM-1 gene expression in endothelial cells without affecting nuclear translocation of nuclear factor-kappa B.
Cobb RR; Felts KA; Parry GC; Mackman N
Eur J Immunol; 1996 Apr; 26(4):839-45. PubMed ID: 8625976
[TBL] [Abstract][Full Text] [Related]
13. Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells.
Han IO; Kim HS; Kim HC; Joe EH; Kim WK
J Neurosci Res; 2003 Sep; 73(5):659-69. PubMed ID: 12929133
[TBL] [Abstract][Full Text] [Related]
14. Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli.
Sareila O; Hämäläinen M; Nissinen E; Kankaanranta H; Moilanen E
J Pharmacol Exp Ther; 2008 Feb; 324(2):858-66. PubMed ID: 18039960
[TBL] [Abstract][Full Text] [Related]
15. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells.
Bae IK; Min HY; Han AR; Seo EK; Lee SK
Eur J Pharmacol; 2005 Apr; 513(3):237-42. PubMed ID: 15862806
[TBL] [Abstract][Full Text] [Related]
16. Hematein inhibits tumor necrotic factor-alpha-induced vascular cell adhesion molecule-1 and NF-kappaB-dependent gene expression in human vascular endothelial cells.
Hong JJ; Jeong TS; Choi JH; Park JH; Lee KY; Seo YJ; Oh SR; Oh GT
Biochem Biophys Res Commun; 2001 Mar; 281(5):1127-33. PubMed ID: 11243852
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
[TBL] [Abstract][Full Text] [Related]
18. NF- kappa B independent suppression of endothelial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 gene expression by inhibition of flavin binding proteins and superoxide production.
Tummala PE; Chen XL; Medford RM
J Mol Cell Cardiol; 2000 Aug; 32(8):1499-508. PubMed ID: 10900176
[TBL] [Abstract][Full Text] [Related]
19. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
[TBL] [Abstract][Full Text] [Related]
20. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
Sahnoun Z; Jamoussi K; Zeghal KM
Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
